SELLAS Life Sciences Group, Inc. Increase Decrease In Operating Lease Liability
SELLAS Life Sciences Group, Inc. (SLS) reported Increase Decrease In Operating Lease Liability of -$318.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-11
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$159.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$159.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$159.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$158.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for fiscal 2025 was -$635.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for fiscal 2024 was -$533.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for fiscal 2023 was -$518.00K.
- SELLAS Life Sciences Group, Inc. increase decrease in operating lease liability for fiscal 2022 was -$471.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$318.00K 10-Q · filed 2026-08-11 | -$477.00K derived: sum of 3 quarters · filed 2026-08-11 | -$635.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$159.00K 10-Q · filed 2026-05-12 | -$318.00K derived: sum of 2 quarters · filed 2026-05-12 | -$476.00K derived: sum of 3 quarters · filed 2026-05-12 | -$635.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$317.00K derived: sum of 2 quarters · filed 2026-03-19 | -$476.00K derived: sum of 3 quarters · filed 2026-08-11 | -$635.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$317.00K derived: sum of 2 quarters · filed 2026-08-11 | -$476.00K 10-Q · filed 2025-11-12 | -$611.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$318.00K 10-Q · filed 2026-08-11 | -$453.00K derived: sum of 3 quarters · filed 2026-08-11 | -$586.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$159.00K 10-Q · filed 2026-05-12 | -$294.00K derived: sum of 2 quarters · filed 2026-05-12 | -$427.00K derived: sum of 3 quarters · filed 2026-05-12 | -$560.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$268.00K derived: sum of 2 quarters · filed 2026-03-19 | -$401.00K derived: sum of 3 quarters · filed 2026-03-19 | -$533.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$266.00K derived: sum of 2 quarters · filed 2025-11-12 | -$398.00K 10-Q · filed 2025-11-12 | -$530.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$265.00K 10-Q · filed 2025-08-12 | -$397.00K derived: sum of 3 quarters · filed 2025-08-12 | -$526.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$132.00K 10-Q · filed 2025-05-13 | -$264.00K derived: sum of 2 quarters · filed 2025-05-13 | -$393.00K derived: sum of 3 quarters · filed 2025-05-13 | -$557.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$261.00K derived: sum of 2 quarters · filed 2025-03-20 | -$425.00K derived: sum of 3 quarters · filed 2025-03-20 | -$518.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$293.00K derived: sum of 2 quarters · filed 2024-11-13 | -$386.00K 10-Q · filed 2024-11-13 | -$513.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$257.00K 10-Q · filed 2024-08-13 | -$384.00K derived: sum of 3 quarters · filed 2024-08-13 | -$595.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$93.00K 10-Q · filed 2024-05-14 | -$220.00K derived: sum of 2 quarters · filed 2024-05-14 | -$431.00K derived: sum of 3 quarters · filed 2024-05-14 | -$515.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$338.00K derived: sum of 2 quarters · filed 2024-03-28 | -$422.00K derived: sum of 3 quarters · filed 2024-03-28 | -$471.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$211.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$295.00K derived: sum of 2 quarters · filed 2023-11-09 | -$344.00K 10-Q · filed 2023-11-09 | -$527.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$133.00K 10-Q · filed 2023-08-10 | -$316.00K derived: sum of 3 quarters · filed 2023-08-10 | -$316.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$49.00K 10-Q · filed 2023-05-11 | -$232.00K derived: sum of 2 quarters · filed 2023-05-11 | -$232.00K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$183.00K derived: sum of 2 quarters · filed 2023-03-16 | -$183.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |